Breast Cancer Resiliency Through Exercise Program (B-REP) - Trial NCT06100263
Access comprehensive clinical trial information for NCT06100263 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Michigan Rogel Cancer Center and is currently Not yet recruiting. The study focuses on Breast Cancer Female. Target enrollment is 60 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of Michigan Rogel Cancer Center
Timeline & Enrollment
N/A
Apr 01, 2024
Oct 01, 2026
Primary Outcome
Feasibility of the exercise program (Retention),Feasibility of the exercise program (Adherence),Feasibility of the exercise program (fidelity),Satisfaction of program,Affective attitude,Perceived burden,Outcome expectation
Summary
The study will use a cross-sectional study design with a follow-up 2-arm randomized
 controlled trial with that has assessments at baseline, post-intervention (i.e., Week 12),
 and 3-months post-intervention (i.e., Week 24). The 2 arms are the 12-week intervention and a
 health education control among 60 Black breast cancer survivors.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06100263
Non-Device Trial